These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
600 related items for PubMed ID: 29761826
1. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants. Jagadeb M, Rath SN, Sonawane A. J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826 [Abstract] [Full Text] [Related]
2. Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Rajendran V, Sethumadhavan R. J Biomol Struct Dyn; 2014 Sep; 32(2):209-21. PubMed ID: 23383724 [Abstract] [Full Text] [Related]
3. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Khan MT, Malik SI, Ali S, Masood N, Nadeem T, Khan AS, Afzal MT. BMC Infect Dis; 2019 Feb 06; 19(1):116. PubMed ID: 30728001 [Abstract] [Full Text] [Related]
4. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N. Junaid M, Khan MT, Malik SI, Wei DQ. J Chem Inf Model; 2019 Jan 28; 59(1):498-508. PubMed ID: 30481017 [Abstract] [Full Text] [Related]
8. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. Tam KK, Leung KS, Siu GK, Chang KC, Wong SS, Ho PL, Leung EK, Yam WC. J Clin Microbiol; 2019 Aug 28; 57(8):. PubMed ID: 31189582 [Abstract] [Full Text] [Related]
9. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. Bwalya P, Yamaguchi T, Mulundu G, Nakajima C, Mbulo G, Solo ES, Fukushima Y, Kasakwa K, Suzuki Y. Tuberculosis (Edinb); 2018 Mar 28; 109():117-122. PubMed ID: 29559115 [Abstract] [Full Text] [Related]
11. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y. Antimicrob Agents Chemother; 1997 Mar 28; 41(3):540-3. PubMed ID: 9055989 [Abstract] [Full Text] [Related]
12. Role of pncA gene mutations W68R and W68G in pyrazinamide resistance. Aggarwal M, Singh A, Grover S, Pandey B, Kumari A, Grover A. J Cell Biochem; 2018 Mar 28; 119(3):2567-2578. PubMed ID: 28980723 [Abstract] [Full Text] [Related]
13. Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That? Werngren J, Alm E, Mansjö M. J Clin Microbiol; 2017 Jun 28; 55(6):1920-1927. PubMed ID: 28404681 [Abstract] [Full Text] [Related]
16. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. Lee KW, Lee JM, Jung KS. J Korean Med Sci; 2001 Oct 28; 16(5):537-43. PubMed ID: 11641519 [Abstract] [Full Text] [Related]
17. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y. Antimicrob Agents Chemother; 2000 Mar 28; 44(3):528-32. PubMed ID: 10681313 [Abstract] [Full Text] [Related]
18. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene. Bhuju S, Fonseca Lde S, Marsico AG, de Oliveira Vieira GB, Sobral LF, Stehr M, Singh M, Saad MH. Infect Genet Evol; 2013 Oct 28; 19():1-6. PubMed ID: 23770140 [Abstract] [Full Text] [Related]
20. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. Liu W, Chen J, Shen Y, Jin J, Wu J, Sun F, Wu Y, Xie L, Zhang Y, Zhang W. Clin Microbiol Infect; 2018 Sep 28; 24(9):1016.e1-1016.e5. PubMed ID: 29288021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]